Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPP.L Regulatory News (APP)

  • There is currently no data for APP

Director/PDMR Shareholding

30 Jul 2018 07:00

RNS Number : 0809W
Park Group PLC
30 July 2018
Β 

Park Group plc

("Park" the "Company" or the "Group")

Director Share Dealing

Β 

The Company has been informed that on 27 July 2018 Martin Stewart, Group Finance Director of Park, acquired 25,000 ordinary shares of 2 pence each in the Company ("Ordinary Shares") at a price of 69 pence per Ordinary Share.

Β 

For further information please contact:

Β 

Park Group plc

Arden Partners plc

Tavistock

Β 

Ian O'Doherty

Β 

Steve Douglas

Benjamin Cryer

Β 

Jeremy Carey

Sophie Praill

Β 

Tel: 0151 653 1700

Β 

Tel: 020 7614 5920

Β 

Tel: 020 7920 3150

Β 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Martin Stewart

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Park Group plc

b)

Β 

LEI

Β 

Β 

213800MQ5U1F8SPHK638

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary shares of 2p each

Β 

Β 

ISIN : GB0006710643

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of ordinary shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.69

25,000

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

N/A (Single transaction)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

27 July 2018

f)

Β 

Place of the transaction

Β 

Β 

XLON

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHRPMRTMBJTMPP
Date   Source Headline
9th Nov 20223:52 pmRNSForm 8.3 - Appreciate Group PLC
9th Nov 20223:45 pmRNSForm 8.3 - Appreciate Group plc
9th Nov 202210:29 amRNSForm 8.3 - Appreciate Group plc
9th Nov 20229:04 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
8th Nov 20223:57 pmRNSForm 8.3 - Appreciate Group
8th Nov 20223:01 pmRNSHolding(s) in Company
8th Nov 202212:49 pmRNSForm 8.3 - Appreciate Group Plc
8th Nov 202212:27 pmRNSForm 8.3 - Appreciate Group PLC
8th Nov 202212:09 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Appreciate Group Plc.
8th Nov 202210:27 amRNSForm 8.3 - Appreciate Group PLC
8th Nov 20229:53 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
8th Nov 20229:39 amRNSForm 8.5 (EPT/RI)
8th Nov 20228:44 amRNSForm 8.3 - Appreciate Group PLC
7th Nov 202212:13 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Appreciate Group plc
7th Nov 20227:00 amRNSAcquisition of Appreciate Group
19th Oct 20227:00 amRNSNotice of Half Year Results
12th Oct 20224:40 pmRNSDirector/PDMR Shareholding
30th Sep 20225:08 pmRNSHolding(s) in Company
30th Sep 20224:20 pmRNSHolding(s) in Company
20th Sep 20222:39 pmRNSResult of AGM
20th Sep 20227:00 amRNSAGM Statement
1st Sep 20227:00 amRNSBoard Update
31st Aug 20227:00 amRNSNotice of AGM
26th Aug 20227:00 amRNSBoard Update
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
3rd Aug 20228:15 amEQSHardman & Co Research: Q&A on Appreciate Group Plc (APP) - Strategic growth, billings and efficiency accelerate company plans
27th Jul 20224:14 pmRNSGrant of Share Options and PDMR Notification
15th Jul 20227:00 amRNSDirector/PDMR Shareholding
15th Jul 20227:00 amRNSDirector/PDMR Shareholding
14th Jul 20227:00 amRNSDirectorate Change
7th Jul 202212:20 pmEQSHardman & Co Research: Appreciate Group (APP) FY’22 results: going for growth
6th Jul 20227:00 amRNSAppointment of Interim CFO
28th Jun 20223:16 pmRNSReplacement: Final Results
28th Jun 20227:01 amRNSAcquisition of MBL Holdco Ltd
28th Jun 20227:00 amRNSFinal Results
28th Apr 20227:00 amRNSYear-end trading update
7th Apr 20221:15 pmEQSHardman & Co Research: Q&A on Appreciate Group plc (APP): Digitising Giving: Delivering the future today
23rd Mar 20227:00 amRNSAppointment of Chairman Designate
17th Mar 202210:45 amEQSHardman & Co Research: Appreciate Group (APP) Digitising giving: delivering the future today
21st Feb 20227:01 amEQSHardman & Co Research : Hardman Talks Video | Appreciate Group Management Presentation and Q&A
7th Feb 202211:30 amEQSHardman Talks Video Event | Appreciate Group Management Presentation and Q&A 'Gifting investors with digitisation'
20th Jan 20224:10 pmRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSQ3 FY22 Trading Update
13th Jan 20227:01 amEQSHardman & Co Video : Demystifying Chesnara - a high-yield investment with a strong degree of predictability and good growth prospects
11th Jan 202210:50 amRNSNotification of Q3 Trading Statement
16th Dec 20214:05 pmEQSHardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mark Thomas on Appreciate Group (APP) | Demonstrating great confidence in long-term growth
13th Dec 20212:57 pmRNSAppreciate Group to present at Mello Monday
29th Nov 20214:00 pmEQSHardman & Co Research: Appreciate Group (APP): Interim results: solid progress, digital delivering
23rd Nov 20217:00 amRNSHalf Year Results
21st Sep 20214:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.